Hikma Pharmaceuticals PLC (FRA:H5P)
17.20
0.00 (0.00%)
At close: Dec 19, 2025
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of €3.82 billion as of December 22, 2025. Its market cap has decreased by -27.18% in one year.
Market Cap
3.82B
Enterprise Value
4.93B
Revenue
2.74B
Ranking
n/a
PE Ratio
12.10
Stock Price
€17.20
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 690.84M to 3.82B, an increase of 453.19%. That is a compound annual growth rate of 8.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 3.82B | -28.49% |
| Dec 31, 2024 | 5.34B | 17.25% |
| Dec 29, 2023 | 4.56B | 18.28% |
| Dec 30, 2022 | 3.85B | -36.98% |
| Dec 31, 2021 | 6.11B | -5.59% |
| Dec 31, 2020 | 6.48B | 13.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.17B |
| Siemens Aktiengesellschaft | 183.73B |
| Allianz SE | 148.10B |
| Deutsche Telekom AG | 130.23B |
| Siemens Energy AG | 102.77B |
| Rheinmetall AG | 71.55B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 62.85B |